Variable Neuroendocrine-immune Dysfunction in Individuals with Unfavorable Outcome After Severe Traumatic Brain Injury

Overview

Journal Brain Behav Immun

Publisher Elsevier

Specialties Allergy & Immunology
Neurology
Psychiatry

Date 2014 Sep 15

PMID 25218898

Citations 28

Authors

M Santarsieri

R G Kumar

P M Kochanek

S Berga

A K Wagner

Affiliations

Soon will be listed here.

Abstract

Bidirectional communication between the immune and neuroendocrine systems is not well understood in the context of traumatic brain injury (TBI). The purpose of this study was to characterize relationships between cerebrospinal fluid (CSF) cortisol and inflammation after TBI, and to determine how these relationships differ by outcome. CSF samples were collected from 91 subjects with severe TBI during days 0-6 post-injury, analyzed for cortisol and inflammatory markers, and compared to healthy controls (n=13 cortisol, n=11 inflammatory markers). Group-based trajectory analysis (TRAJ) delineated subpopulations with similar longitudinal CSF cortisol profiles (high vs. low cortisol). Glasgow Outcome Scale (GOS) scores at 6months served as the primary outcome measure reflecting global outcome. Inflammatory markers that displayed significant bivariate associations with both GOS and cortisol TRAJ (interleukin [IL]-6, IL-10, soluble Fas [sFas], soluble intracellular adhesion molecule [sICAM]-1, and tumor necrosis factor alpha [TNF]-α) were used to generate a cumulative inflammatory load score (ILS). Subsequent analysis revealed that cortisol TRAJ group membership mediated ILS effects on outcome (indirect effect estimate=-0.253, 95% CI (-0.481, -0.025), p=0.03). Correlational analysis between mean cortisol levels and ILS were examined separately within each cortisol TRAJ group and by outcome. Within the low cortisol TRAJ group, subjects with unfavorable 6-month outcome displayed a negative correlation between ILS and mean cortisol (r=-0.562, p=0.045). Conversely, subjects with unfavorable outcome in the high cortisol TRAJ group displayed a positive correlation between ILS and mean cortisol (r=0.391, p=0.006). Our results suggest that unfavorable outcome after TBI may result from dysfunctional neuroendocrine-immune communication wherein an adequate immune response is not mounted or, alternatively, neuroinflammation is prolonged. Importantly, the nature of neuroendocrine-immune dysfunction differs between cortisol TRAJ groups. These results present a novel biomarker-based index from which to discriminate outcome and emphasize the need for evaluating tailored treatments targeting inflammation early after injury.

Citing Articles

The role of the stress system in recovery after traumatic brain injury: A tribute to Bruce S. McEwen.

Weil Z, White B, Whitehead B, Karelina K Neurobiol Stress. 2022; 19:100467.

PMID: 35720260 PMC: 9201063. DOI: 10.1016/j.ynstr.2022.100467.

Acute Cortisol Profile Associations With Cognitive Impairment After Severe Traumatic Brain Injury.

Barton D, Kumar R, Schuster A, Juengst S, Oh B, Wagner A Neurorehabil Neural Repair. 2021; 35(12):1088-1099.

PMID: 34689657 PMC: 8688285. DOI: 10.1177/15459683211048771.

Early chronic systemic inflammation and associations with cognitive performance after moderate to severe TBI.

Milleville K, Awan N, DiSanto D, Kumar R, Wagner A Brain Behav Immun Health. 2021; 11:100185.

PMID: 34589725 PMC: 8474517. DOI: 10.1016/j.bbih.2020.100185.

Profiling the Expression of Circulating Acute-Phase Proteins, Cytokines, and Checkpoint Proteins in Patients with Severe Trauma: A Pilot Study.

Wu S, Rau C, Kuo P, Shih F, Lin H, Wu Y J Inflamm Res. 2021; 14:3739-3753.

PMID: 34393495 PMC: 8354739. DOI: 10.2147/JIR.S324056.

A Histological and Morphometric Assessment of the Adult and Juvenile Rat Livers after Mild Traumatic Brain Injury.

Prus R, Appelhans O, Logash M, Pokotylo P, Nowicki G, Slusarska B Cells. 2021; 10(5).

PMID: 34066539 PMC: 8148537. DOI: 10.3390/cells10051121.

References

Wagner A, McCullough E, Niyonkuru C, Ozawa H, Loucks T, Dobos J . Acute serum hormone levels: characterization and prognosis after severe traumatic brain injury. J Neurotrauma. 2011; 28(6):871-88. PMC: 3113446. DOI: 10.1089/neu.2010.1586. View

CARROLL , Curtis G, MENDELS J . Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. Arch Gen Psychiatry. 1976; 33(9):1039-44. DOI: 10.1001/archpsyc.1976.01770090029002. View

Rivest S . Regulation of innate immune responses in the brain. Nat Rev Immunol. 2009; 9(6):429-39. DOI: 10.1038/nri2565. View

Chrousos G . The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995; 332(20):1351-62. DOI: 10.1056/NEJM199505183322008. View

Hurley S, Olschowka J, OBanion M . Cyclooxygenase inhibition as a strategy to ameliorate brain injury. J Neurotrauma. 2002; 19(1):1-15. DOI: 10.1089/089771502753460196. View

Correale J, Villa A . The neuroprotective role of inflammation in nervous system injuries. J Neurol. 2004; 251(11):1304-16. DOI: 10.1007/s00415-004-0649-z. View

Pace T, Hu F, Miller A . Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun. 2006; 21(1):9-19. PMC: 1820632. DOI: 10.1016/j.bbi.2006.08.009. View

Sapolsky R, Romero L, Munck A . How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000; 21(1):55-89. DOI: 10.1210/edrv.21.1.0389. View

Kirchhoff C, Buhmann S, Bogner V, Stegmaier J, Leidel B, Braunstein V . Cerebrospinal IL-10 concentration is elevated in non-survivors as compared to survivors after severe traumatic brain injury. Eur J Med Res. 2008; 13(10):464-8. View

10.

Van den Berghe G, de Zegher F, Bouillon R . Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab. 1998; 83(6):1827-34. DOI: 10.1210/jcem.83.6.4763. View

11.

Andaluz-Ojeda D, Bobillo F, Iglesias V, Almansa R, Rico L, Gandia F . A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine. 2011; 57(3):332-6. DOI: 10.1016/j.cyto.2011.12.002. View

12.

Roubenoff R, Harris T, Abad L, Wilson P, Dallal G, Dinarello C . Monocyte cytokine production in an elderly population: effect of age and inflammation. J Gerontol A Biol Sci Med Sci. 1998; 53(1):M20-6. DOI: 10.1093/gerona/53a.1.m20. View

13.

Reichlin S . Neuroendocrine-immune interactions. N Engl J Med. 1993; 329(17):1246-53. DOI: 10.1056/NEJM199310213291708. View

14.

McClain C, Cohen D, Phillips R, Ott L, Young B . Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J Lab Clin Med. 1991; 118(3):225-31. View

15.

Zafonte R, Friedewald W, Lee S, Levin B, Diaz-Arrastia R, Ansel B . The citicoline brain injury treatment (COBRIT) trial: design and methods. J Neurotrauma. 2009; 26(12):2207-16. PMC: 2824223. DOI: 10.1089/neu.2009.1015. View

16.

Wagner A, Zitelli K . A Rehabilomics focused perspective on molecular mechanisms underlying neurological injury, complications, and recovery after severe TBI. Pathophysiology. 2012; 20(1):39-48. DOI: 10.1016/j.pathophys.2012.02.007. View

17.

Meisel C, Schwab J, Prass K, Meisel A, Dirnagl U . Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci. 2005; 6(10):775-86. DOI: 10.1038/nrn1765. View

18.

Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G . Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004; 364(9442):1321-8. DOI: 10.1016/S0140-6736(04)17188-2. View

19.

Rahman A, Fazal F . Hug tightly and say goodbye: role of endothelial ICAM-1 in leukocyte transmigration. Antioxid Redox Signal. 2008; 11(4):823-39. PMC: 2850296. DOI: 10.1089/ars.2008.2204. View

20.

Morganti-Kossmann M, Satgunaseelan L, Bye N, Kossmann T . Modulation of immune response by head injury. Injury. 2007; 38(12):1392-400. DOI: 10.1016/j.injury.2007.10.005. View